Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | CA12 | O43570 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | NT5E | P21589 | 1/20 | 0.56 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenolsulfonic Acid SCHEMBL10622999 | 0.97 | LMNA (1.00) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL29965481 | 0.97 | LMNA (1.00) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL18275 | 0.97 | LMNA (1.00) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL687364 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL20815893 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL2518117 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL9682015 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL560246 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL8781964 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 | |
| Phenolsulfonic Acid SCHEMBL125057 | 0.94 | LMNA (0.94) | LMNAALDH1A1CA2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11850294-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2023-12-26 | — | — | US | claimed |
| CN-116574037-A | Continuous synthesis method of calcium dobesilate | 宁夏元康药业有限公司 | 2023-08-11 | — | — | CN | claimed |
| US-20220079849-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | FIDELITY DIRECT LENDING LLC, AS ADMINISTRATIVE AGENT | 2022-03-17 | — | — | US | claimed |
| EP-1868940-B1 | OBTAINING AMMONIUM DINITRAMIDE (ADN) CRYSTALS | HERAKLES (FR) | 2017-09-20 | — | — | EP | claimed |
| US-7789980-B2 | Preparation of ammonium dinitroamide (ADN) crystals, ADN crystals and energetic composites containing them | SNPE MATERIAUX ENERGETIQUES (FR) | 2010-09-07 | — | — | US | claimed |
| US-20090090441-A1 | Preparation of Ammonium Dinitroamide (ADN) Crystals, ADN Crystals and Energetic Composites Containing Them | SNPE MATERIAUX ENERGETIQUES (FR) | 2009-04-09 | — | — | US | claimed |
| CN-114839293-B | Quantitative determination method for genotoxic impurities in calcium dobesilate | 南京长澳医药科技有限公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-114839293-B | Quantitative determination method for genotoxic impurities in calcium dobesilate | 南京长澳医药科技有限公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-114380723-A | Para hydroxybenzene sulfonate compound and preparation method and application thereof | 成都益安成贸易有限公司 | 2022-04-22 | — | — | CN | disclosed |
| CN-113744821-A | Information detection method and device and storage medium | 北京京东拓先科技有限公司 | 2021-12-03 | — | — | CN | disclosed |
| CN-109280306-A | A kind of preparation method of Polymethacrylimide composite foam conduction absorbing material | 浙江中科恒泰新材料科技有限公司 | 2019-01-29 | — | — | CN | disclosed |
| CN-103597021-B | Irradiated fluoropolymer articles with low leachable fluoride ions | ARKEMA INC. (US) | 2015-11-25 | — | — | CN | disclosed |
| US-8889161-B2 | Microencapsulated compositions and methods for tissue mineralization | PREMIER DENTAL PRODUCTS COMPANY (US) | 2014-11-18 | — | — | US | disclosed |
| CN-1757389-A | Implanted agent for preventing and treating biabetic retinopathy | DUAN YADONG (CN) | 2006-04-12 | — | — | CN | disclosed |
| CN-1037007-C | Oil-soluble adducts of disuccinimides and anhydrides of unsaturated bicarboxylic aliphatic acids | AGIP PETROLI (IT) | 1998-01-14 | — | — | CN | disclosed |
| CN-1101934-A | Oil-soluble adducts of disuccinimides and anhydrides of unsaturated bicarboxylic aliphatic acids | AGIP PETROLI (IT) | 1995-04-26 | — | — | CN | disclosed |
| EP-0125641-B1 | ALKANOYLOXYBENZENESULFONATE SALT PRODUCTION | ETHYL CORPORATION (US) | 1987-03-04 | — | — | EP | disclosed |
| US-4544503-A | REACTING HYDROXY BENZENESULFONATE WITH CARBON MONOXIDE AND OLEFIN | ETHYL CORPORATION (US) | 1985-10-01 | — | — | US | disclosed |
| US-4537724-A | Alkanoyloxybenzenesulfonate salt production | ETHYL CORPORATION (US) | 1985-08-27 | — | — | US | disclosed |
| EP-0125641-A2 | Alkanoyloxybenzenesulfonate salt production | ETHYL CORPORATION (US) | 1984-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11850294-B2 | Buffered microencapsulated compositions and methods | CHMP4B, LIPA, APOB | LMNA 930/4885ALDH1A1 3804/4885CA2 690/4885 |
| US-20220079849-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | CHMP4B, LIPA, APOB | LMNA 930/4885ALDH1A1 3804/4885CA2 690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.